genOway Shanghai - Legal letter - Product name change

Intellectual property

Event
-
June 27, 2025

In an effort to align our global catalog, our product naming strategy will now be consistent across both our Chinese and French teams' communication and documentation.

Access legal letter here

genOway Shanghai - Legal letter - Product name change

Get in touch

Let us know how we can help

Other news & events

Lunch & Learn, April 14th: Accelerating Drug Development Through Predictive and Translatable In Vivo Models
genOway presentation
Event
-
Apr 2026
Read on
genOway Shanghai at AntibodyChina 2026: The 9th Antibody Therapeutics & ADC Focus Summit
Conference
Event
-
Apr 2026
Read on
AACR Annual Meeting 2026, San Diego, CAL, April 17-22
Conference
genOway presentation
Event
-
Mar 2026
Read on
Revolutionizing the Prediction of Antibody Therapies in Humans with a Unique Mouse Model
Partnership
News
-
Feb 2026
Read on
NextGen Biomed 2026, London, UK, March 24-25
Conference
Event
-
Feb 2026
Read on
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe